$159.34
0.07% yesterday
Nasdaq, Aug 08, 10:00 pm CET
ISIN
US0576652004
Symbol
BCPC

Balchem Corporation Stock price

$159.34
-3.60 2.21% 1M
-0.05 0.03% 6M
-3.66 2.24% YTD
-8.84 5.26% 1Y
+31.57 24.71% 3Y
+56.52 54.97% 5Y
+98.05 159.98% 10Y
+149.92 1,591.11% 20Y
Nasdaq, Closing price Fri, Aug 08 2025
-0.11 0.07%
ISIN
US0576652004
Symbol
BCPC
Sector
Industry

Key metrics

Basic
Market capitalization
$5.2b
Enterprise Value
$5.3b
Net debt
$126.4m
Cash
$65.4m
Shares outstanding
32.5m
Valuation (TTM | estimate)
P/E
36.5 | 30.8
P/S
5.2 | 5.0
EV/Sales
5.4 | 5.1
EV/FCF
34.6
P/B
4.1
Dividends
DPS
$0.87
Yield 1Y | 5Y
0.6% | 0.5%
Growth 1Y | 5Y
10.1% | 10.8%
Payout 1Y | 3Y
22.1% | 22.5%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$985.9m | $1.0b
EBITDA
$242.1m | $277.3m
EBIT
$197.9m | $210.5m
Net Income
$142.8m | $168.0m
Free Cash Flow
$153.1m
Growth (TTM | estimate)
Revenue
5.8% | 8.7%
EBITDA
8.4% | 19.5%
EBIT
16.8% | 14.4%
Net Income
22.2% | 30.8%
Free Cash Flow
-3.5%
Margin (TTM | estimate)
Gross
35.8%
EBITDA
24.6% | 26.7%
EBIT
20.1%
Net
14.5% | 16.2%
Free Cash Flow
15.5%
Financial Health
Equity Ratio
73.0%
Return on Equity
11.2%
ROCE
12.9%
ROIC
9.9%
Debt/Equity
0.2
More
EPS
$4.4
FCF per Share
$4.7
Short interest
2.0%
Employees
1k
Rev per Employee
$690.0k
Show more

Is Balchem Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Balchem Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Balchem Corporation forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Balchem Corporation forecast:

Buy
88%
Hold
13%

Financial data from Balchem Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
986 986
6% 6%
100%
- Direct Costs 633 633
3% 3%
64%
353 353
12% 12%
36%
- Selling and Administrative Expenses 136 136
2% 2%
14%
- Research and Development Expense 18 18
13% 13%
2%
242 242
8% 8%
25%
- Depreciation and Amortization 44 44
18% 18%
4%
EBIT (Operating Income) EBIT 198 198
17% 17%
20%
Net Profit 143 143
22% 22%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Balchem Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Balchem Corporation Stock News

Positive
The Motley Fool
8 days ago
Balchem (BCPC 0.24%), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue and non-GAAP profits, well surpassing analyst expectations for Q2 FY2025.
Neutral
Seeking Alpha
8 days ago
Balchem Corporation (NASDAQ:BCPC ) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Lee Harris - CEO, President & Chairman Conference Call Participants Anthony Polak - Unidentified Company Aegis Capital Corp. - Unidentified Company Daniel Scott Harriman - Sidoti & Com...
Neutral
GlobeNewsWire
9 days ago
MONTVALE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025.
More Balchem Corporation News

Company Profile

marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.

Head office United States
CEO Theodore Harris
Employees 1,379
Founded 1967
Website balchem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today